Latest filing published 03 Oct 2017 for Regeneron Pharmaceuticals, INC., €32k.
Filing timeline
BuySaleInsider track record
Charles A. Baker: trading record in brief
Charles A. Baker is a declared insider at 2 companies; the most frequent names are Regeneron Pharmaceuticals, Inc. and Progenics Pharmaceuticals Inc. We count 156 filings; the first trade dates from 1 February 2006 and the latest from 29 September 2017.
Every open-market trade on record is a sale: 95 sales worth €22.3M. Outside the open market, there are 60 option exercises. 2017 to date brings no purchases and 1 sale.
Most recently, on 3 October 2017, the filings show an open-market sale worth €764k in Regeneron Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles A. Baker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$18.611.6% of flowCommon StockSEC:0001237899-17-000023:0
- 2,000 shares@ US$450.0038.9% of flowCommon StockSEC:0001237899-17-000023:1
- 3,000 shares@ US$18.612.7% of flowCommon StockSEC:0001237899-16-000085:0
- 600 shares@ US$390.6711.3% of flowCommon StockSEC:0001237899-16-000085:1
- 1,200 shares@ US$391.3622.7% of flowCommon StockSEC:0001237899-16-000085:2
- 400 shares@ US$392.417.6% of flowCommon StockSEC:0001237899-16-000085:3
- 600 shares@ US$393.6411.4% of flowCommon StockSEC:0001237899-16-000085:4
- 200 shares@ US$394.333.8% of flowCommon StockSEC:0001237899-16-000085:5
- 5,000 shares@ US$18.61Common StockSEC:0001237899-15-000052:0
- 5,000 shares@ US$550.00Common StockSEC:0001237899-15-000052:1
- 5,000 shares@ US$18.61Common StockSEC:0001237899-15-000028:0
- 300 shares@ US$452.45Common StockSEC:0001237899-15-000028:1
- 265 shares@ US$453.71Common StockSEC:0001237899-15-000028:2
- 1,999 shares@ US$454.38Common StockSEC:0001237899-15-000028:3
- 1,536 shares@ US$455.48Common StockSEC:0001237899-15-000028:4
- 700 shares@ US$456.36Common StockSEC:0001237899-15-000028:5
- 200 shares@ US$457.21Common StockSEC:0001237899-15-000028:6
- 15,000 shares@ US$23.84Common StockSEC:0001237899-14-000035:0
- 10,200 shares@ US$300.09Common StockSEC:0001237899-14-000035:1
- 700 shares@ US$301.12Common StockSEC:0001237899-14-000035:2
- 100 shares@ US$302.90Common StockSEC:0001237899-14-000035:3
- 300 shares@ US$303.64Common StockSEC:0001237899-14-000035:4
- 300 shares@ US$304.42Common StockSEC:0001237899-14-000035:5
- 200 shares@ US$305.25Common StockSEC:0001237899-14-000035:6
- 300 shares@ US$307.65Common StockSEC:0001237899-14-000035:7
25 of 146 declarations
